Clara Campas
Overview
Explore the profile of Clara Campas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Villoslada P, Rovira A, Montalban X, Arroyo R, Paul F, Meca-Lallana V, et al.
Neurol Neuroimmunol Neuroinflamm
. 2015 Sep;
2(5):e147.
PMID: 26405686
Objective: The aim of this study was to test the safety of diazoxide and to search for signs of efficacy in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: In this...
2.
Montraveta A, Xargay-Torrent S, Rosich L, Lopez-Guerra M, Roldan J, Rodriguez V, et al.
Oncotarget
. 2015 Jun;
6(25):21159-72.
PMID: 26110568
Acadesine is a nucleoside analogue with known activity against B-cell malignancies. Herein, we showed that in mantle cell lymphoma (MCL) cells acadesine induced caspase-dependent apoptosis through turning on the mitochondrial...
3.
Montraveta A, Xargay-Torrent S, Lopez-Guerra M, Rosich L, Perez-Galan P, Salaverria I, et al.
Oncotarget
. 2014 Feb;
5(3):726-39.
PMID: 24519895
Mantle cell lymphoma (MCL) is considered one of the most challenging lymphoma, with limited responses to current therapies. Acadesine, a nucleoside analogue has shown antitumoral effects in different preclinical cancer...
4.
Van den Neste E, Cazin B, Janssens A, Gonzalez-Barca E, Terol M, Levy V, et al.
Cancer Chemother Pharmacol
. 2012 Dec;
71(3):581-91.
PMID: 23228986
Purpose: Acadesine has shown in vitro to selectively induce apoptosis in B cells from chronic lymphocytic leukemia (CLL) patients. We conducted a phase I/II open-label clinical study, to determine the...
5.
Santidrian A, Gonzalez-Girones D, Iglesias-Serret D, Coll-Mulet L, Cosialls A, de Frias M, et al.
Blood
. 2010 Jul;
116(16):3023-32.
PMID: 20664053
5-Aminoimidazole-4-carboxamide riboside or acadesine (AICAR) induces apoptosis in chronic lymphocytic leukemia (CLL) cells. A clinical study of AICAR is currently being performed in patients with this disease. Here, we have...
6.
Rojo F, Gracias E, Villena N, Cruz T, Corominas J, Corradino I, et al.
Clin Cancer Res
. 2010 Apr;
16(8):2474-82.
PMID: 20371675
Purpose: To assess the pharmacodynamic effects of nimotuzumab, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody with intermediate affinity for the receptor, in skin and tumor tissues from head and...
7.
Rojo F, Gonzalez-Navarrete I, Bragado R, Dalmases A, Menendez S, Cortes-Sempere M, et al.
Clin Cancer Res
. 2009 May;
15(10):3530-9.
PMID: 19417026
Purpose: Mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) dephosphorylates mitogen-activated protein kinase [extracellular signal-regulated kinase (ERK), c-Jun NH(2)-terminal kinase (JNK), and p38], mediates breast cancer chemoresistance, and is repressible by doxorubicin...
8.
Campas C
Drug News Perspect
. 2009 Mar;
22(2):126-8.
PMID: 19330171
The Third Annual Drug Repositioning Summit 2008 was held at the Hyatt Harborside Hotel in Boston, Massachusetts, October 6-7, and focused on new strategies for drug repositioning. The meeting, organized...
9.
Santidrian A, Cosialls A, Coll-Mulet L, Iglesias-Serret D, de Frias M, Gonzalez-Girones D, et al.
Haematologica
. 2007 Dec;
92(12):1631-8.
PMID: 18055986
Background And Objectives: The potential anticancer agent 1-(2-chlorophenyl-N-methylpropyl)-3-isoquinolinecarboxamide (PK11195), a translocator protein (18KDa) (TSPO) ligand, facilitates the induction of cell death by a variety of cytotoxic and chemotherapeutic agents. Primary...
10.
Campas C, Cosialls A, Barragan M, Iglesias-Serret D, Santidrian A, Coll-Mulet L, et al.
Exp Hematol
. 2006 Dec;
34(12):1663-9.
PMID: 17157163
Objective: Antiapoptotic Bcl-2 is overexpressed in most cases of chronic lymphocytic leukemia (CLL). The inhibition of the antiapoptotic Bcl-2 proteins is an attractive strategy for either restoring normal apoptotic process...